Milan, Italy-based Dianax has received a €2 million European Union grant to support development of a portable diagnostic for the prevention and monitoring of diabetes. The device is designed to provide measurements of glycated haemoglobin. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
